Destabilizing the genome as a therapeutic strategy to enhance response to immune checkpoint blockade: a systematic review of clinical trials evidence from solid and hematological tumors. - Alotaibi F; Alshammari K; Alotaibi BA; Alsaab H (Frontiers in pharmacology, 2024)